Antibody-based pharmaceuticals resource

In this episode, we will introduce four aspects of ribosome display, including introduction to ribosome display technology, principle of ribosome display, it's system, and advantages and applications of ribosome display.

In this episode, we will introduce phages, phagemid structure, and the process of phage library construction and screening.

Bacterial display is a protein engineering technique widely used for in vitro protein evolution. In this episode, many aspects of bacterial display will be illustrated, such as cell surface display system in gram-positive/negative bacteria, components of bacterial display systems, construction and screening process of bacterial display library, and application of bacterial display.

This episode is a brief introduction to in vitro diagnostic (IVD) antibody development, which includes the introduction to background, principle, and process of antibody development, difficulties in antibody development, as well as the antibody services of Creative Biolabs.

Prostate cancer is the most common cancer among men and predominately affects elderly men with a higher incidence. Deregulated production and secretion of growth factors by stromal cells within the PCa microenvironment, as well as mutations in androgen signaling pathway components and further physiological modifications, potentially lead to systemic recurrence of prostate cancer, including the app...

Pancreatic cancer is one of the malignant tumors with strong invasiveness, high degree of deterioration, and low surgical resection rate in the digestive system. Optimizing early diagnosis and developing targeted therapy of pancreatic cancer are the key to improving the survival rate of patients. In the episode, we will give you a comprehensive introduction to pancreatic cancer and its signaling p...

Endometrial cancer is the most common female genital cancer in the developed world. In the United States of America, an estimated 2.8% of women will be diagnosed with this malignancy at some point in their lifetime. Therefore, in order to improve the benefit of screening and the survival rate of patients, it is very important to establish a system of early diagnosis and targeted therapy for endome...

Thyroid cancer (TC) remains the most common endocrine malignancy worldwide and its incidence and mortality have increased steadily over the last four decades. Thyroid cancer is commonly diagnosed at a younger age than most other adult cancers. Therefore, in order to improve the benefit of screening and the survival rate of patients, it is very important to establish a system of early diagnosis and...

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This is a 10-minute conversation about motivations for next-generation ADCs. If you are interested in ADC-related services, please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This is a 10-minute conversation about next generation payloads for ADCs. If you are interested in ADC-related services, please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This is a 10-minute conversation about combining ADCs with immuno oncology. If you are interested in ADC-related services, please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. In this episode, we will explore strategies for developing higher DAR ADCs. If you want to know more about our payload technology, please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This is a 10-minute conversation about site-specific antibody-drug conjugates. If you are interested in ADC-related services, please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This episode is about bispecific and biparatopic ADCs. If you are interested in ADC-related services,  please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. Today, we are talking about probody drug conjugates, a drug targeting conjugate to the tumor microenvironment. If you want to learn more information about ADC, please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This episode is about ADCs targeting the tumor microenvironment. If you are interested in tumor targeting ADC, please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This episode is about ADCs beyond oncology. If you want to learn more about ADC, please follow us.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. This episode describes the basic knowledge of antibody-drug conjugates, including introduction, structural composition, mechanism of action, toxicity risk, and development trends.

Creative Biolabs has archived professional academic reports and the latest scientific progress of antibody-drug conjugates, by making it into a podcast column. In this episode, we will illustrate detailed information, such as structure and timeline of antibody-drug conjugate (ADC), mechanism of action of ADC, and approved ADC drugs for marketing.